CITADEL ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share (VTYX)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share
Symbol
VTYX
Shares outstanding
70,480,050 shares
Disclosed Ownership
1,409,601 shares
Ownership
2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 17:29:54 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 2% 1,393,033 0 1,393,033 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 2% 1,393,033 0 1,393,033 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 2% 1,393,033 0 1,393,033 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 16,263 0 16,263 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0% 16,568 0 16,568 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0% 16,568 0 16,568 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 2% 1,409,601 0 1,409,601 /s/ Seth Levy Seth Levy, attorney-in-fact*